 鲜花( 85)  鸡蛋( 2)
|
楼主 |
发表于 2015-2-28 21:48
|
显示全部楼层
Stock soars after Cold-fX wins crucial approval
! x7 j7 a* L3 |0 q) M g2 R. c9 _# u * p" W; j; f* L, K* e$ E
EDMONTON - CV Technologies Inc. shares rose nearly 60 per cent Thursday after Health Canada approved the claims at the core of the company's marketing of its cold and flu drug Cold-fX.! Z: J) D1 P. Q/ ~6 `
) V6 C Y( t8 `BY THE EDMONTON JOURNAL FEBRUARY 16, 2007# P& I6 {; L; M* \- F
) c* q3 e6 L6 s& @0 A# H
4 J9 m0 k+ W- a% @( J9 E" @EDMONTON - CV Technologies Inc. SHARES rose nearly 60 per cent Thursday after Health Canada approved the claims at the core of the company's marketing of its cold and flu drug Cold-fX.
7 |6 T( x4 r0 X5 v9 u1 m5 V: | P3 S
The agency said CV Technologies can continue to market Cold-fX as helping "to reduce the frequency, severity and duration of cold and flu symptoms by boosting the IMMUNE SYSTEM."
2 l! z! h! D* S( E3 ]# ?( V' r9 I* i z4 z2 U. n% c# ~+ _/ b5 ?/ |
The APPROVAL follows a review of seven clinical trials and more than 10 years of research about the product.7 H D5 m x4 J, b2 _
/ I* z. N6 w; T4 _2 r% CIt should create even more confidence among consumers and medical professionals that the product works, CEO Jacqueline Shan said Thursday.
* k! {0 J5 i. e7 S
$ a% n, a! _+ A& i5 c aIt certainly instilled confidence in the market, as shares closed at $2.90 on THE TORONTO STOCK EXCHANGE, up $1.08 on a volume of 4.6 million.
& b$ u7 K/ z! D8 Q9 D9 {7 u
. C% K% W2 Z; M: ^! C& u2 G"As a scientist, it's one of the highlights of my CAREER," Shan said.$ B# [ Q6 R# L) e* t2 e I, B
- H* ^; D4 V2 H0 o5 W3 x8 c
"This approval is a breakthrough in realizing our vision of being a global leader in developing products for disease prevention."
0 N" P7 X% h' @& h' `+ Q1 P6 D H/ W/ P
It's Cold-fX's strongest medical recognition to date, said Shan. It means the company can advertise the HEALTH BENEFITS more effectively to consumers and health professionals, she said.
1 {9 i7 a3 E0 m- ~# N" {9 W, K- i, Z }9 i# ?: z. V
Ginseng-based Cold-fX is already the top-selling cold and flu treatment in Canada, but Shan said there is plenty of room for more growth.
- }. C$ ^8 H. b. d1 P6 \4 T* a9 w! w& [# p
The approval will also help raise the product's PROFILE in the lucrative U.S. market, which Cold-fX entered in October. The move came with a new marketing push, using former Oilers superstar Mark Messier as its spokesman.
% Y4 c) E' v9 U( @: @5 c( p' R* ]$ [% Y8 N+ M& \
8 N6 \* D% X C3 c
http://www.canada.com/story.html ... 9-be80-f40f1426f662 |
|
狗仔卡
发表于 2015-2-28 18:25
提升卡
置顶卡
沉默卡
喧嚣卡
变色卡
显身卡
1 Y/ _7 C: p9 y1 `$ Q
发表于 2015-2-28 19:45
